Pub Date : 2022-12-19DOI: 10.51737/2766-5232.2022.017
Mohiuddin Ak
Proper use of medicine or taking medicine in correct order is essential to cure any disease. According to the WHO, lack of adherence to treatment regimens leads to major problems among patients, mostly with chronic illnesses. "Right administration" depends on at least 5 right factors--right patient, right drug, right time, right dose and right route. "Medicines won't work if you don't take it right"--This simple fact is not understood by most people in the world, as a result still more than half of the patients with chronic diseases in the developed world do not take their medicine correctly-says WHO.
{"title":"Taking Medicine in the Right Way: Most Important But Most Neglected","authors":"Mohiuddin Ak","doi":"10.51737/2766-5232.2022.017","DOIUrl":"https://doi.org/10.51737/2766-5232.2022.017","url":null,"abstract":"Proper use of medicine or taking medicine in correct order is essential to cure any disease. According to the WHO, lack of adherence to treatment regimens leads to major problems among patients, mostly with chronic illnesses. \"Right administration\" depends on at least 5 right factors--right patient, right drug, right time, right dose and right route. \"Medicines won't work if you don't take it right\"--This simple fact is not understood by most people in the world, as a result still more than half of the patients with chronic diseases in the developed world do not take their medicine correctly-says WHO.","PeriodicalId":131899,"journal":{"name":"SunText Review of Pharmaceutical Sciences","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128114726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.51737/2766-5232.2020.002
Alekhya Ch, Krishnamurty Vs
A simple, precise, accurate and robust RP-HPLC method was developed and validated for the determination of dasatinib in bulk and its Tablets, Nano-suspension drug entrapment efficiency and serum. The software used is EZ Chrome and the column employed is Syncronis C18 (250 mm × 4.6 mm, 5 μm particle size). Acetonitrile: Methanol: water 45:35:20 (v/v) was used as mobile phase at a flow rate of 1 mL min with UV detection at 325 nm. Linearity was observed in the concentration range of 1–6 μg mL with regression equation y =40966x-6534(R = 0.999). The Nanosuspension prepared by novel precipitation-combined ultra-sonic homogenization technique and was then characterized by using particle size analysis, zeta potential measurement. Liquidliquid extraction is performed for isolation of the drug and elimination of serum interferences samples of serum was extracted with 50μL of ortho phosphoric acid and 3ml of methanol was added and spiked with dasatinib. The method was validated as per ICH guidelines. The RSD for intra-day (99.2) and inter-day (98.3) precision were found to be less than 2 %.The developed method is simple, precise and robust for the determination of dasatinib in bulk and applied to tablets, Nano-suspension, drug entrapment efficiency and serum.
建立了一种简便、准确、可靠的反相高效液相色谱(RP-HPLC)测定达沙替尼原料药及其片剂含量、纳米悬浮液包封效率和血清含量的方法。所用软件为EZ Chrome，色谱柱为Syncronis C18 (250 mm × 4.6 mm，粒径5 μm)。以乙腈:甲醇:水45:35:20 (v/v)为流动相，流速为1 mL min，紫外检测波长为325 nm。在1 ~ 6 μ mL浓度范围内呈线性关系，回归方程为y =40966x-6534(R = 0.999)。采用新型沉淀-超声均质技术制备了纳米混悬液，并利用粒径分析、zeta电位测量对其进行了表征。液液萃取分离药物，消除血清干扰，取血清样品，取50μL邻位磷酸，加入3ml甲醇，加达沙替尼;该方法按照ICH指南进行了验证。日内(99.2)和日间(98.3)精密度的RSD均小于2%。该方法简便、准确、可靠，可用于达沙替尼原料药的含量测定，适用于片剂、纳米悬浮液、药物包封效率和血清。
{"title":"RP-HPLC Method for Development and Validation of Dasatinib in Bulk, Tablets Applied in Nano suspension, Drug Entrapment Efficiency and Serum","authors":"Alekhya Ch, Krishnamurty Vs","doi":"10.51737/2766-5232.2020.002","DOIUrl":"https://doi.org/10.51737/2766-5232.2020.002","url":null,"abstract":"A simple, precise, accurate and robust RP-HPLC method was developed and validated for the determination of dasatinib in bulk and its Tablets, Nano-suspension drug entrapment efficiency and serum. The software used is EZ Chrome and the column employed is Syncronis C18 (250 mm × 4.6 mm, 5 μm particle size). Acetonitrile: Methanol: water 45:35:20 (v/v) was used as mobile phase at a flow rate of 1 mL min with UV detection at 325 nm. Linearity was observed in the concentration range of 1–6 μg mL with regression equation y =40966x-6534(R = 0.999). The Nanosuspension prepared by novel precipitation-combined ultra-sonic homogenization technique and was then characterized by using particle size analysis, zeta potential measurement. Liquidliquid extraction is performed for isolation of the drug and elimination of serum interferences samples of serum was extracted with 50μL of ortho phosphoric acid and 3ml of methanol was added and spiked with dasatinib. The method was validated as per ICH guidelines. The RSD for intra-day (99.2) and inter-day (98.3) precision were found to be less than 2 %.The developed method is simple, precise and robust for the determination of dasatinib in bulk and applied to tablets, Nano-suspension, drug entrapment efficiency and serum.","PeriodicalId":131899,"journal":{"name":"SunText Review of Pharmaceutical Sciences","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122448306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.51737/2766-5232.2021.008
V. S
ARTICLE DETAILS Nowadays herbs are increasingly being used worldwide as therapeutic agents or in collaboration with minerals and vitamins in health supplements, teas etc. There are many advantages of herbalism over modern or conventional medicine such as the herbal/traditional systems of medicine causes lesser side effects than modern medicine; herbal medicine along with lifestyle modification enhances its potency by assisting and boosting the inborn self-healing mechanisms of the patient. Thus, the chronic disorder is not only cured but the possibilities of its recurrence are highly reduced. However, despite having great in-vitro potential, herbs or herbal extracts have demonstrated very less in-vivo activity due to insufficient lipid solubility and irregular molecular size. Thus, this led to poor absorption and poor bioavailability. With the advancement in science and technology, several trials are undergone to enhance the bioavailability of drugs via novel drug delivery systems such as microspheres, nanoparticles, liposomes, transferosomes, lipid-based systems, etc. Besides these novel approaches, there are certain compounds that exist in nature that are found to exhibit enhanced bioavailability rate such as piperine, curcumin, naringin, quercetin, genistein, etc. The objective of this review is to throw light on bioavailability enhancing effects of these natural bioenhancers of herbal origin, their characteristic features and mechanisms of action.
{"title":"A Strategy to Enhance Bioavailability of Drug Candidates: Natural Bioenhancers","authors":"V. S","doi":"10.51737/2766-5232.2021.008","DOIUrl":"https://doi.org/10.51737/2766-5232.2021.008","url":null,"abstract":"ARTICLE DETAILS Nowadays herbs are increasingly being used worldwide as therapeutic agents or in collaboration with minerals and vitamins in health supplements, teas etc. There are many advantages of herbalism over modern or conventional medicine such as the herbal/traditional systems of medicine causes lesser side effects than modern medicine; herbal medicine along with lifestyle modification enhances its potency by assisting and boosting the inborn self-healing mechanisms of the patient. Thus, the chronic disorder is not only cured but the possibilities of its recurrence are highly reduced. However, despite having great in-vitro potential, herbs or herbal extracts have demonstrated very less in-vivo activity due to insufficient lipid solubility and irregular molecular size. Thus, this led to poor absorption and poor bioavailability. With the advancement in science and technology, several trials are undergone to enhance the bioavailability of drugs via novel drug delivery systems such as microspheres, nanoparticles, liposomes, transferosomes, lipid-based systems, etc. Besides these novel approaches, there are certain compounds that exist in nature that are found to exhibit enhanced bioavailability rate such as piperine, curcumin, naringin, quercetin, genistein, etc. The objective of this review is to throw light on bioavailability enhancing effects of these natural bioenhancers of herbal origin, their characteristic features and mechanisms of action.","PeriodicalId":131899,"journal":{"name":"SunText Review of Pharmaceutical Sciences","volume":"192 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133481000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.51737/2766-5232.2022.013
Iwatsuki N, B. H, O. M
Latest Standards of Medical Care in Diabetes was presented in January 2022. Among oral hypoglycemic agents (OHAs), imeglimin has been topic for a novel agent for type 2 diabetes mellitus (T2DM). Pharmacologically, imeglimin is a cyclic molecule including triazine ring. It has both pharmacological mechanism of increased insulin action and elevation of glucose-stimulated insulin secretion (GSIS). Clinically, it showed HbA1c reduction for 0.46% by monotherapy and 0.56-0.92% by combined therapy with other OHAs. From compared administration of 500mg, 1000mg and 1500mg, 1000mg twice doses would be adequate. No remarkable treatment-emergent adverse events (TEAEs) were found for treatment of imeglimin.
{"title":"Pharmacological Characteristic of Imeglimin (Twymeeg) For Dual Mechanism to Insulin Secretion and Resistance","authors":"Iwatsuki N, B. H, O. M","doi":"10.51737/2766-5232.2022.013","DOIUrl":"https://doi.org/10.51737/2766-5232.2022.013","url":null,"abstract":"Latest Standards of Medical Care in Diabetes was presented in January 2022. Among oral hypoglycemic agents (OHAs), imeglimin has been topic for a novel agent for type 2 diabetes mellitus (T2DM). Pharmacologically, imeglimin is a cyclic molecule including triazine ring. It has both pharmacological mechanism of increased insulin action and elevation of glucose-stimulated insulin secretion (GSIS). Clinically, it showed HbA1c reduction for 0.46% by monotherapy and 0.56-0.92% by combined therapy with other OHAs. From compared administration of 500mg, 1000mg and 1500mg, 1000mg twice doses would be adequate. No remarkable treatment-emergent adverse events (TEAEs) were found for treatment of imeglimin.","PeriodicalId":131899,"journal":{"name":"SunText Review of Pharmaceutical Sciences","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125607262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.51737/2766-5232.2022.016
Ghongade Kd
{"title":"Advanced Therapeutic Strategies for Antimalarial and Antibacterial Drug Development through Lactate and Nitrite Transport","authors":"Ghongade Kd","doi":"10.51737/2766-5232.2022.016","DOIUrl":"https://doi.org/10.51737/2766-5232.2022.016","url":null,"abstract":"","PeriodicalId":131899,"journal":{"name":"SunText Review of Pharmaceutical Sciences","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133938980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.51737/2766-5232.2022.014
Nandan M, Samantaray Us
{"title":"Evaluation of Antioxidant Activities from Biosynthesized Copper Nanoparticles (AO-Cunps) Using A. Officinalis Leaf Extracts","authors":"Nandan M, Samantaray Us","doi":"10.51737/2766-5232.2022.014","DOIUrl":"https://doi.org/10.51737/2766-5232.2022.014","url":null,"abstract":"","PeriodicalId":131899,"journal":{"name":"SunText Review of Pharmaceutical Sciences","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122622518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.51737/2766-5232.2021.012
Raoofi Asl Soofiani M, W. H
{"title":"Microemulsions and Micellar Systems as Increasingly Popular Carriers of Biologically Active Compounds and Drugs – Review","authors":"Raoofi Asl Soofiani M, W. H","doi":"10.51737/2766-5232.2021.012","DOIUrl":"https://doi.org/10.51737/2766-5232.2021.012","url":null,"abstract":"","PeriodicalId":131899,"journal":{"name":"SunText Review of Pharmaceutical Sciences","volume":"154 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132859656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.51737/2766-5232.2022.015
K. P., Diniatik K, Hakim Zr
{"title":"Xanthine Oxidase Inhibitor Activity of Dichloromethane Fraction, Ethyl Acetate Fraction of Ethanol Extract of Nephelium Lappaceum L. Leaves","authors":"K. P., Diniatik K, Hakim Zr","doi":"10.51737/2766-5232.2022.015","DOIUrl":"https://doi.org/10.51737/2766-5232.2022.015","url":null,"abstract":"","PeriodicalId":131899,"journal":{"name":"SunText Review of Pharmaceutical Sciences","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122178598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.51737/2766-5232.2020.003
Mohsina Fp, A Nesar, M. Mukim, S. Roy, P. Sharma, Faheem Ip
{"title":"Ebola Disease: Challenges for Medical Professionals","authors":"Mohsina Fp, A Nesar, M. Mukim, S. Roy, P. Sharma, Faheem Ip","doi":"10.51737/2766-5232.2020.003","DOIUrl":"https://doi.org/10.51737/2766-5232.2020.003","url":null,"abstract":"","PeriodicalId":131899,"journal":{"name":"SunText Review of Pharmaceutical Sciences","volume":"132 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132695693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：